GlassScriptPhysician profile
Robert D Clayton
NPI 1558436907
$408.92
in general payments reported to CMS, 2019-2025
17 companies · $17.79 in 2025
The $17.79 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.03 · 2020: $12.01 · 2021: $66.38 · 2022: $153 · 2023: $18.02 · 2024: $91.01 · 2025: $17.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $70.35 | 2022 | |
| Novo Nordisk INC | $44.46 | 2022 | |
| Lilly USA, LLC | $32.08 | 2022-2024 | Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.97 | 2022-2025 | Xifaxan |
| Avanir Pharmaceuticals, INC. | $24.56 | 2019 | |
| 180 Medical, INC. | $23.78 | 2021 | |
| Jazz Pharmaceuticals INC. | $22.68 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $21.24 | 2024 | Rexulti |
| Pfizer INC. | $19.92 | 2021 | |
| Lundbeck LLC | $19.07 | 2024 | Rexulti |
| Mylan Specialty L.P. | $18.02 | 2023 | Yupelri |
| Exact Sciences Corporation | $17.52 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $14.30 | 2019 | |
| Linus Health, INC. | $14.16 | 2024 | Core Cognitive Evaluation |
| Athena Bioscience, LLC | $12.63 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $12.17 | 2019 | |
| Merck Sharp & Dohme LLC | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.